Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

162
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
162
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

444
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

40
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
40

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The AI-native health science institution innovation theater vs. structural redesign.

npj health systems·2026
Same author

From performance to practice: knowledge-distilled segmentator for on-premises clinical workflows.

npj health systems·2026
Same author

Bio-effects of engineering nanomaterials NiFe-based LDHs on ryegrass-soil system.

Advanced biotechnology·2026
Same author

Hemodynamic-guided V-A ECMO management for cardiogenic shock: Insight from initial experience from TWEET study (to wean an ECMO trials).

Perfusion·2026
Same author

RescueGPT: An Automated System for Detecting Adverse Safety Events in Prehospital Emergency Medical Service Notes With a Zero-Shot Approach With Large Language Models: A Proof-of-Concept Study.

Learning health systems·2026
Same author

Wrinkled Photonic Elastomers with Dynamic Structural Color Patterns for Multilevel Optical Anti-Counterfeiting.

Gels (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jun 4, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

949

Simulate Scientific Reasoning with Multiple Large Language Models: An Application to Alzheimer's Disease

Qidi Xu1, Xiaozhong Liu2, Xiaoqian Jiang1

  • 1McWilliams School of Biomedical Informatics, UTHealth Houston, Houston, TX, 77030.

Medrxiv : the Preprint Server for Health Sciences
|December 23, 2024
PubMed
Summary

This study introduces an AI framework using large language models (LLMs) to predict effective combinatorial therapies. The AI approach significantly outperforms traditional methods, offering a novel solution for hypothesis generation in biological inference.

More Related Videos

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.1K
Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

9.3K

Related Experiment Videos

Last Updated: Jun 4, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

949
Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.1K
Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

9.3K

Area of Science:

  • Artificial Intelligence in Medicine
  • Computational Biology
  • Drug Discovery

Background:

  • Data-driven prediction of combinatorial therapies is often infeasible due to limited experimental data.
  • Traditional knowledge-based methods have limitations in predicting complex therapeutic interactions.

Purpose of the Study:

  • To develop an AI-driven framework utilizing large language models (LLMs) to simulate scientific reasoning and peer review.
  • To predict efficacious combinatorial therapies in scenarios where data-driven prediction is not viable.

Main Methods:

  • The framework integrates LLMs to mimic scientific reasoning and peer review processes.
  • It incorporates few-shot learning, external knowledge, self-consistency checks, and internal review mechanisms.
  • The approach focuses on knowledge-driven hypothesis generation.

Main Results:

  • The proposed framework achieved a prediction accuracy of 0.74, outperforming traditional knowledge-based prediction (0.52).
  • External validation using private experimental data demonstrated a high accuracy of 0.82.
  • Ablation studies confirmed the critical role of high-quality examples, external knowledge, and self-consistency.

Conclusions:

  • The AI framework provides an automated and effective method for generating high-quality hypotheses in biological inference.
  • This approach offers a viable alternative for combinatorial therapy prediction when data is scarce.
  • The developed framework has the potential to accelerate drug discovery and therapeutic development.